Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.09M Buy
18,115
+152
+0.8% +$38.3K 1.28% 16
2026
Q1
$4.35M Sell
17,963
-379
-2% -$103K 1.23% 25
2025
Q4
$5.43M Sell
18,342
-180
-1% -$53.9K 1.57% 14
2025
Q3
$5.19M Sell
18,522
-2,835
-13% -$742K 1.51% 16
2025
Q2
$6.3M Sell
21,357
-93
-0.4% -$24K 2.04% 5
2025
Q1
$5.33M Buy
21,450
+41
+0.2% +$10K 1.83% 11
2024
Q4
$4.71M Buy
+21,409
New +$4.77M 1.58% 15
2024
Q3
Sell
-21,568
Closed -$3.71M 431
2024
Q2
$3.71M Sell
21,568
-58
-0.3% -$10.1K 1.33% 22
2024
Q1
$4.13M Sell
21,626
-1,151
-5% -$210K 1.49% 13
2023
Q4
$3.73M Sell
22,777
-313
-1% -$47.3K 1.42% 17
2023
Q3
$3.24M Buy
+23,090
New +$3.29M 1.34% 21
2023
Q1
$2.95M Buy
22,514
+1,771
+9% +$237K 1.19% 24
2022
Q4
$2.92M Buy
+20,743
New +$2.86M 1.18% 25

Other funds holding IBM

Pathway Financial Advisers's IBM Position: Q2 2026 in Review

Pathway Financial Advisers increased its IBM (IBM) stake by 0.85% in Q2 2026, buying an estimated $38.3K and bringing the position to 18,115 shares worth $5.09M. The position accounts for 1.28% of the portfolio, ranked #16.

Pathway Financial Advisers first reported a position in IBM in Q4 2022 and has held it in 13 quarters since. The position peaked at $6.3M in Q2 2025. 1,808 funds tracked by Wall St. Rank hold IBM as of Q2 2026.

  • Pathway Financial Advisers held 18,115 shares of IBM worth $5.09M as of Q2 2026.
  • Pathway Financial Advisers bought 152 IBM shares in Q2 2026, an estimated $38.3K.
  • IBM made up 1.28% of Pathway Financial Advisers's portfolio in Q2 2026, its #16 holding.
  • Pathway Financial Advisers first reported a position in IBM in Q4 2022 and has held it in 13 quarters since.
  • Pathway Financial Advisers's IBM position peaked at $6.3M in Q2 2025.
  • 1,808 funds tracked by Wall St. Rank held IBM as of Q2 2026.

Based on Pathway Financial Advisers's 13F filing for Q2 2026, filed 30 Jul 2026.